The qualitative scale showed that 60% (3/5) of patients with NASH-fibrosis were low positive for CPS1 and none of the simple steatosis patients were found to be low positive (p = 0.01). This evidence concerns the gene CPS1 and metabolic dysfunction-associated steatohepatitis.